睡眠薬の世界市場レポート2025年

睡眠薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.0％で353億米ドルに成長します。

成長予測は、個別化治療アプローチへの関心の高まり、睡眠関連研究への投資の高まり、デジタルヘルスツールを通じた認知度の向上、ハーブや自然睡眠治療薬の人気の高まり、睡眠時無呼吸症候群やその他の関連疾患の罹患率の上昇によって促進されます。今後の主な動向としては、ドラッグデリバリーシステムの革新、徐放性製剤の改良、睡眠追跡のためのウェアラブル技術の出現、認知行動療法を組み込んだデジタルツール、睡眠障害を対象とした併用療法の創出などが挙げられます。

精神疾患の有病率の増加は、今後数年間の睡眠薬市場の成長を牽引すると予想されます。精神疾患には、気分、認知、行動、日常生活機能全般に影響を及ぼすさまざまな精神衛生状態が含まれます。精神疾患の増加に大きく寄与しているのは慢性的なストレスであり、ストレスは脳機能を損ない、精神疾患を悪化させる可能性があります。睡眠薬は、このような状態ではしばしば損なわれる睡眠の質を改善することで、精神疾患の管理に重要な役割を果たします。睡眠薬は睡眠と覚醒のサイクルを整え、不眠や不安などの症状を緩和し、全体的な精神的・機能的健康を改善します。例えば、2022年、米国国立精神衛生研究所（National Institute of Mental Health）の報告によると、米国の18歳以上の成人5,930万人が精神疾患を経験しており、これは成人総人口の23.1％に相当します。このように精神疾患の罹患率が高まっていることが、睡眠薬市場の拡大に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の睡眠薬：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の睡眠薬市場：成長率分析
• 世界の睡眠薬市場の実績：規模と成長, 2019-2024
• 世界の睡眠薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の睡眠薬：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の睡眠薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方薬
• OTC薬
• 世界の睡眠薬市場：睡眠障害タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不眠症
• 睡眠時無呼吸症候群
• むずむず脚症候群
• ナルコレプシー
• 夢遊病
• その他の睡眠障害
• 世界の睡眠薬市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ベンゾジアゼピン
• 抗うつ薬
• 抗ヒスタミン薬
• 鎮静性抗精神病薬
• その他の薬物クラス
• 世界の睡眠薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の睡眠薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 在宅ケア
• 専門センター
• その他のエンドユーザー
• 世界の睡眠薬市場、処方薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ベンゾジアゼピン
• 非ベンゾジアゼピン系睡眠薬
• メラトニン受容体作動薬
• オレキシン受容体拮抗薬
• 抗うつ薬
• 抗精神病薬
• 抗ヒスタミン薬
• 世界の睡眠薬市場、OTC薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• メラトニンサプリメント
• ハーブサプリメント
• 栄養補助食品
• ホメオパシー療法

第7章 地域別・国別分析

• 世界の睡眠薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の睡眠薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 睡眠薬市場：競合情勢
• 睡眠薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Limited
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Limited
• Perrigo Company plc
• H. Lundbeck A/S
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Limited
• Cipla Limited
• Lupin Limited
• Zydus Lifesciences Limited
• Torrent Pharmaceuticals Limited
• Alembic Pharmaceuticals Limited
• Vanda Pharmaceuticals Inc.
• Natrol LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 睡眠薬市場2029：新たな機会を提供する国
• 睡眠薬市場2029：新たな機会を提供するセグメント
• 睡眠薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sleep medication refers to drugs specifically formulated to assist individuals in falling asleep more quickly, staying asleep longer, or enhancing the overall quality of their sleep. These medications are primarily used to manage sleep disorders such as insomnia by helping regulate the body's natural sleep-wake cycle.

Sleep medications are broadly categorized into prescription drugs and over-the-counter (OTC) options. Prescription drugs require authorization from a medical professional due to their strength, possible side effects, and the necessity for supervision. Sleep disorders addressed by these medications include insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleepwalking, among others. These medications are further classified into categories such as benzodiazepines, antidepressants, antihistamines, sedating antipsychotics, and others. They are distributed through hospital pharmacies, online platforms, and retail pharmacies, catering to key end-users including hospitals, homecare settings, specialty centers, and others.

The sleep medication market research report is one of a series of new reports from The Business Research Company that provides sleep medication market statistics, including the sleep medication industry global market size, regional shares, competitors with the sleep medication market share, detailed sleep medication market segments, market trends, and opportunities, and any further data you may need to thrive in the sleep medication industry. This sleep medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sleep medication market size has grown strongly in recent years. It will grow from $23.94 billion in 2024 to $25.92 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%.

Key factors driving historical growth include the increasing reliance on prescription sleep aids, a surge in chronic diseases that interfere with sleep, rising mental health concerns, a growing preference for OTC sleep products, and the expanding use of digital health and telemedicine services.

The sleep medication market size is expected to see strong growth in the next few years. It will grow to $35.30 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%.

Forecasted growth will be fueled by a growing interest in personalized treatment approaches, heightened investments in sleep-related research, enhanced awareness via digital health tools, increasing popularity of herbal and natural sleep remedies, and a rising incidence of sleep apnea and other associated conditions. Key upcoming trends include innovation in drug delivery systems, improvements in sustained-release formulations, the emergence of wearable technologies for sleep tracking, digital tools incorporating cognitive behavioral therapy, and the creation of combination therapies targeting sleep disorders.

The increasing prevalence of mental illness is expected to drive the growth of the sleep medication market in the coming years. Mental illness encompasses a variety of mental health conditions that affect mood, cognition, behavior, and overall daily functioning. A significant contributor to the rise in mental illness is chronic stress, which can impair brain function and exacerbate mental health disorders. Sleep medications play a crucial role in managing mental illness by improving sleep quality, which is frequently compromised in these conditions. These medications help regulate the sleep-wake cycle, alleviate symptoms such as insomnia and anxiety, and improve overall mental and functional health. For example, in 2022, the National Institute of Mental Health reported that 59.3 million adults aged 18 and older in the United States experienced mental illness, representing 23.1% of the total adult population. This growing incidence of mental illness is thus fueling the expansion of the sleep medication market.

Companies in the sleep medication market are increasingly developing innovative solutions, such as dual orexin receptor antagonists (DORAs), to provide more targeted treatments for insomnia with fewer side effects and a lower risk of dependence. DORAs work by inhibiting the activity of orexin neuropeptides, which are responsible for promoting wakefulness, by blocking both orexin receptors (OX1R and OX2R). This mechanism helps regulate the sleep-wake cycle without directly sedating the brain. For instance, in January 2022, Idorsia Pharmaceuticals Ltd., a pharmaceutical company based in Switzerland, received approval from the U.S. Food and Drug Administration (FDA) for QUVIVIQ (daridorexant) 25 mg and 50 mg. This DORA treatment is intended for adult patients with insomnia and works by blocking wake-promoting orexins to support better sleep regulation.

In July 2024, Cosette Pharmaceuticals Inc., a U.S.-based pharmaceutical company, strengthened its presence in the U.S. sleep medicine market by acquiring Ambien (zolpidem tartrate), a fast-acting sleep medication, and Ambien CR tablets (6.25 mg once daily before bedtime) from Sanofi S.A. for an undisclosed amount. This acquisition adds well-established insomnia treatments to Cosette's portfolio. Sanofi S.A., headquartered in France, is a pharmaceutical company known for its development of sleep medications.

Major players in the sleep medication market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Perrigo Company plc, H. Lundbeck A/S, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Vanda Pharmaceuticals Inc., Natrol LLC.

North America was the largest region in the sleep medication market in 2024. The regions covered in sleep medication report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sleep medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sleep medication market consists of sales of hormonal sleep aids, anticonvulsants, cannabinoids, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sleep Medication Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sleep medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sleep medication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sleep medication market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Prescription-Based Drugs; Over-The-Counter (OTC) Drugs
• 2) By Sleep Disorder Type: Insomnia; Sleep Apnea; Restless Legs Syndrome; Narcolepsy; Sleep Walking; Other Sleep Disorders
• 3) By Drug Class; Benzodiazepines: Antidepressants; Antihistamines; Sedating Antipsychotics; Other Drug Classes
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End-Users: Hospitals; Homecare; Speciality Centres; Other End-Users
• Subsegments:
• 1) By Prescription-Based Drugs: Benzodiazepines; Non-Benzodiazepine Hypnotics; Melatonin Receptor Agonists; Orexin Receptor Antagonists; Antidepressants; Antipsychotics; Antihistamines
• 2) By Over-The-Counter (OTC) Drugs: Antihistamines; Melatonin Supplements; Herbal Supplements; Dietary Supplements; Homeopathic Remedies
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Sanofi S.A.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sleep Medication Market Characteristics

3. Sleep Medication Market Trends And Strategies

4. Sleep Medication Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sleep Medication Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sleep Medication PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sleep Medication Market Growth Rate Analysis
• 5.4. Global Sleep Medication Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sleep Medication Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sleep Medication Total Addressable Market (TAM)

6. Sleep Medication Market Segmentation

• 6.1. Global Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription-Based Drugs
• Over-The-Counter (OTC) Drugs
• 6.2. Global Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insomnia
• Sleep Apnea
• Restless Legs Syndrome
• Narcolepsy
• Sleep Walking
• Other Sleep Disorders
• 6.3. Global Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Benzodiazepines
• Antidepressants
• Antihistamines
• Sedating Antipsychotics
• Other Drug Classes
• 6.4. Global Sleep Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Sleep Medication Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Speciality Centres
• Other End-Users
• 6.6. Global Sleep Medication Market, Sub-Segmentation Of Prescription-Based Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Benzodiazepines
• Non-Benzodiazepine Hypnotics
• Melatonin Receptor Agonists
• Orexin Receptor Antagonists
• Antidepressants
• Antipsychotics
• Antihistamines
• 6.7. Global Sleep Medication Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Melatonin Supplements
• Herbal Supplements
• Dietary Supplements
• Homeopathic Remedies

7. Sleep Medication Market Regional And Country Analysis

• 7.1. Global Sleep Medication Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sleep Medication Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sleep Medication Market

• 8.1. Asia-Pacific Sleep Medication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sleep Medication Market

• 9.1. China Sleep Medication Market Overview
• 9.2. China Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sleep Medication Market

• 10.1. India Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sleep Medication Market

• 11.1. Japan Sleep Medication Market Overview
• 11.2. Japan Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sleep Medication Market

• 12.1. Australia Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sleep Medication Market

• 13.1. Indonesia Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sleep Medication Market

• 14.1. South Korea Sleep Medication Market Overview
• 14.2. South Korea Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sleep Medication Market

• 15.1. Western Europe Sleep Medication Market Overview
• 15.2. Western Europe Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sleep Medication Market

• 16.1. UK Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sleep Medication Market

• 17.1. Germany Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sleep Medication Market

• 18.1. France Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sleep Medication Market

• 19.1. Italy Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sleep Medication Market

• 20.1. Spain Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sleep Medication Market

• 21.1. Eastern Europe Sleep Medication Market Overview
• 21.2. Eastern Europe Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sleep Medication Market

• 22.1. Russia Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sleep Medication Market

• 23.1. North America Sleep Medication Market Overview
• 23.2. North America Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sleep Medication Market

• 24.1. USA Sleep Medication Market Overview
• 24.2. USA Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sleep Medication Market

• 25.1. Canada Sleep Medication Market Overview
• 25.2. Canada Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sleep Medication Market

• 26.1. South America Sleep Medication Market Overview
• 26.2. South America Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sleep Medication Market

• 27.1. Brazil Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sleep Medication Market

• 28.1. Middle East Sleep Medication Market Overview
• 28.2. Middle East Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sleep Medication Market

• 29.1. Africa Sleep Medication Market Overview
• 29.2. Africa Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sleep Medication Market Competitive Landscape And Company Profiles

• 30.1. Sleep Medication Market Competitive Landscape
• 30.2. Sleep Medication Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Sleep Medication Market Other Major And Innovative Companies

• 31.1. Takeda Pharmaceutical Company Limited
• 31.2. Teva Pharmaceutical Industries Limited
• 31.3. Eisai Co. Ltd.
• 31.4. Sun Pharmaceutical Industries Limited
• 31.5. Perrigo Company plc
• 31.6. H. Lundbeck A/S
• 31.7. Aurobindo Pharma Limited
• 31.8. Dr. Reddy's Laboratories Limited
• 31.9. Cipla Limited
• 31.10. Lupin Limited
• 31.11. Zydus Lifesciences Limited
• 31.12. Torrent Pharmaceuticals Limited
• 31.13. Alembic Pharmaceuticals Limited
• 31.14. Vanda Pharmaceuticals Inc.
• 31.15. Natrol LLC

32. Global Sleep Medication Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sleep Medication Market

34. Recent Developments In The Sleep Medication Market

35. Sleep Medication Market High Potential Countries, Segments and Strategies

• 35.1 Sleep Medication Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sleep Medication Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sleep Medication Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer